FDA approves over-the-counter Narcan. Here's what it means

The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription. Wednesday's approval is for Narcan, a name-brand version of naloxone sold by Emergent BioSolutions.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Jose Benitez ,Keith Humphreys ,Maya Doe Simkins ,Purdue Pharma ,Harm Reduction Therapeutics Inc ,Stanford University ,Us Centers For Medicaid ,Drug Administration On ,Medicare Services ,Drug Administration ,Maryland Based Emergent Biosolutions ,Prevention Point Philadelphia ,For The People ,